Patient-Reported Aesthetic Outcomes of Botulinum Toxin Type A: A Systematic Review and Meta-Analysis of Placebo-Controlled Randomized Trials

Clicks: 19
ID: 332858
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #85 of 129 articles by views in Aesthetic surgery journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 129 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Botulinum toxin type A (BoNT-A) is widely used for facial rejuvenation, but patient-perceived benefit is best evaluated against an inert control. This systematic review assessed whether BoNT-A, compared with placebo, vehicle, or saline placebo, improves aesthetic self-perception and related patient-reported outcomes. PubMed/MEDLINE, Embase, Scopus, Web of Science, and CENTRAL were searched from inception through September 25, 2026 using a sensitivity-oriented strategy. Randomized controlled trials in adults were eligible when they contained an extractable BoNT-A-versus-placebo contrast and a patient-reported aesthetic outcome. Seventy-five reports were retained: 70 contributed direct comparative evidence from 65 unique placebo-containing RCTs enrolling 18,581 participants across all randomized arms, and five linked reports were retained only for contextual mapping. Four clinically homogeneous responder subsets were quantitatively pooled; all favored BoNT-A, with pooled risk ratios ranging from 5.53 to 14.74 and I2=0% in each analysis. BoNT-A consistently improved treatment or appearance satisfaction, patient-rated facial-line severity or bother, perceived age/youthfulness, and selected appearance-related psychosocial outcomes. Overall RoB 2 was Low in 39/65 RCTs (60.0%) and Some concerns in 26/65 (40.0%). GRADE certainty was moderate for satisfaction/global aesthetic improvement, patient-reported facial-line severity/appearance appraisal, and perceived age/naturalness; low for appearance-related psychological well-being; and very low for general quality-of-life/self-esteem constructs. Placebo-controlled evidence supports a consistent patient-perceived aesthetic benefit of BoNT-A, while broader psychological and quality-of-life claims remain less certain.
Reference Key
openalex_W7222920183 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vicente Antonio Jesús Fernandois Barrera, Kiara Alexandra Maldonado Rodriguez, Alain Chaple-Gil, Javier Basualdo, Eduardo Maximiliano Fernández Godoy
Are you one of these authors? Claim your profile
Journal Aesthetic surgery journal
Year 2026
DOI
10.1093/asj/sjag236
URL
https://doi.org/10.1093/asj/sjag236
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.